Schizophrenia-Psychotic Disorders & Antipsychotics

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

3! - Reasons for discontinuing clozapine: matched, case–control comparison with risperidone long-acting injection

David M. Taylor, Petrina Douglas-Hall, Banke Olofinjana, Eromona Whiskey, Arwel Thomas

The British Journal of Psychiatry (2009) 194: 165-167

3 - Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis

P. Fusar-Poli, A. Meneghelli, L. Valmaggia, P. Allen, F. Galvan, P. McGuire, A. Cocchi

The British Journal of Psychiatry (2009) 194: 181-182

5 - A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia

Stefan Leucht, Katja Komossa, Christine Rummel-Kluge, Caroline Corves, Heike Hunger, Franziska Schmid, Claudia Asenjo Lobos, Sandra Schwarz, and John M. Davis

Am J Psychiatry 2009; 166:152-163

3! - Stability of medication in early psychosis: a comparison between second-generation and low-dose first-generation antipsychotics

Stein Opjordsmoen, Ingrid Melle, Svein Friis, Ulrik Haahr, Jan O. Johannessen, Tor K. Larsen, Bjørn R. Rund, Erik Simonsen, Per Vaglum and Thomas H. McGlashan

Early Intervention in Psychiatry. Volume 3 Issue 1, Pages 58 - 65

 

3! - Predictors of poor adherence to medication among patients with first-episode schizophrenia-spectrum disorder

Phuong Le Quach, Ole Mors, Torben Østergaard Christensen, Gertrud Krarup, Per Jørgensen, Mette Bertelsen, Pia Jeppesen, Lone Petersen, Anne Thorup and Merete Nordentoft

Early Intervention in Psychiatry. Volume 3 Issue 1, Pages 66 - 74

 

3 - Recent advances in treating cognitive impairment in schizophrenia

Review

Recent advances in treating cognitive impairment in schizophrenia

Cherrie Galletly

Psychopharmacology. Volume 202, Numbers 1-3 / Jan 2009: 259-273

 

3 - Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat—a back translational study

Original Investigation

Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat—a back translational study

Pascal Goetghebeur and Rebecca Dias

Psychopharmacology. Volume 202, Numbers 1-3 / January, 2009: 287-293

 

3 - Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions

Original Investigation

Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions

David S. Tait, Hugh M. Marston, Mohammed Shahid and Verity J. Brown

Psychopharmacology. Volume 202, Numbers 1-3 / January, 2009: 295-306

 

3 - Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D_2/3 receptor antagonist sulpiride

Original Investigation

Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D_2/3 receptor antagonist sulpiride

Marie A. Pezze, Jeffrey W. Dalley and Trevor W. Robbins

Psychopharmacology. Volume 202, Numbers 1-3 / January, 2009: 307-313

 

3 - Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D₁ and serotonin 5-HT_1A receptors

Original Investigation

Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D₁ and serotonin 5-HT_1A receptors

Taku Nagai, Rina Murai, Kanae Matsui, Hiroyuki Kamei, Yukihiro Noda, Hiroshi Furukawa and Toshitaka Nabeshima

Psychopharmacology. Volume 202, Numbers 1-3 / January, 2009: 315-328

 

3 - Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat

Original Investigation

Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat

Mark D. Black, Geoffrey B. Varty, Michal Arad, Segev Barak, Amaya De Levie, Denis Boulay, Philippe Pichat, Guy Griebel and Ina Weiner

Psychopharmacology. Volume 202, Numbers 1-3 / January, 2009: 385-396

 

GRATIS 5< - A placebo-controlled study of sildenafil effects on cognition in schizophrenia

Original Investigation

A placebo-controlled study of sildenafil effects on cognition in schizophrenia

Donald C. Goff, Corinne Cather, Oliver Freudenreich, David C. Henderson, A. Eden Evins, Melissa A. Culhane and Jared P. Walsh

Psychopharmacology. Volume 202, Numbers 1-3 / January, 2009: 411-417

 

3! - Electrophysiological characterization of the effects of asenapine at 5-HT_1A, 5-HT_2A, α₂-adrenergic and D₂ receptors in the rat brain

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Ramez Ghanbari, Mostafa El Mansari, Mohammed Shahid and Pierre Blier

European Neuropsychopharmacology. Volume 19, Issue 3, March 2009, Pages 177-187

 

3 - Pharmacotherapy of patients with schizophrenia and substance abuse

Thomas Wobrock‌ & Michael Soyka

Expert Opinion on Pharmacotherapy. February 2009, Vol. 10, No. 3, Pages 353-367

 

3! - Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Alessandro Guidotti, Erbo Dong, Marija Kundakovic, Rosalba Satta, Dennis R. Grayson and Erminio Costa

Trends in Pharmacological Sciences. Volume 30, Issue 2, February 2009, Pages 55-60

 

GRATIS 3! - Psychotic Illness in First-Time Mothers with No Previous Psychiatric Hospitalizations: A Population-Based Study

Valdimarsdóttir U, Hultman CM, Harlow B, Cnattingius S, Sparén P

PLoS Med 2009, 6(2): e1000013

 

3! - Neuroleptic Malignant Syndrome Complicating Antipsychotic Treatment of Delirium or Agitation in Medical and Surgical Patients: Case Reports and A Review of the Literature

Dallas P. Seitz, Sudeep S. Gill

Psychosomatics 2009; 50:8-15, January-February

GRATIS 3 - Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study

Frank D Gianfrancesco, Gahan Pandina, Ramy Mahmoud, Jasmanda Wu and Ruey H Wang

Annals of General Psychiatry 2009, 8:5

 

3! - Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects

Mei Han, Xu-Feng Huang and Chao Deng

The International Journal of Neuropsychopharmacology February 2009

 

5 - Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial

H Afshar, H Roohafza, G Mousavi, S Golchin, N Toghianifar, M Sadeghi, M Talaei

Journal of Psychopharmacology, Vol. 23, No. 2, 157-162 (2009)

3 - Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour

L Dahan, H Husum, O Mnie-Filali, J Arnt, P Hertel, N Haddjeri

Journal of Psychopharmacology, Vol. 23, No. 2, 177-189 (2009)

3 - Clozapine: more than 900 mg/day may be needed

C MacCall, N Billcliff, W Igbrude, S Natynczuk, EP Spencer, RJ Flanagan

Journal of Psychopharmacology, Vol. 23, No. 2, 206-210 (2009)

3! - Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting

Ho-Jun Seo, Young-Eun Jung, Young Sup Woo, Tae-Youn Jun, Jeong-Ho Chae, Won-Myong Bahk

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 2, Pages 135 - 143

 

GRATIS 3! - Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone

Hong Liu-Seifert, Bruce J Kinon, Christopher J Tennant, Jennifer Sniadecki, Jan Volavka

Neuropsychiatric Disease and Treatment. Early On Line. January 2009

 

GRATIS 3 - Combination therapy or monotherapy for the depressed type of schizoaffective disorder

Lubomira Izáková, Ivan Andre, Angelos Halaris

Neuropsychiatric Disease and Treatment. Early On Line. February 2009

 

3 - Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver

Original Investigation

Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver

Johan Fernø, Audun O. Vik-Mo, Goran Jassim, Bjarte Håvik, Kjetil Berge, Silje Skrede, Oddrun A. Gudbrandsen, Jo Waage, Niclas Lunder, Sverre Mørk, Rolf K. Berge, Hugo A. Jørgensen and Vidar M. Steen

Psychopharmacology. Volume 203, Number 1 / March, 2009: 73-84

 

3! - Sensitivity of Older Patients to Antipsychotic Motor Side Effects: A PET Study Examining Potential Mechanisms

Uchida, Hiroyuki; Kapur, Shitij; Mulsant, Benoit H.; Graff-Guerrero, Ariel; Pollock, Bruce G.; Mamo, David C

American Journal of Geriatric Psychiatry: March 2009 - Volume 17 - Issue 3 - pp 255-263

 

GRATIS 3! - The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: a retrospective study

Maureen J Lage and Mariam K Hassan

Annals of General Psychiatry 2009, 8:7

 

3 - Atypical antipsychotic use in pregnancy: a retrospective review

Short Communication

Atypical antipsychotic use in pregnancy: a retrospective review

Christina L. Wichman

Archives of Women's Mental Health. Volume 12, Number 1 / February, 2009: 53-57

 

3 - Antipsychotic-Like Effect of Retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic Acid Ester], a KCNQ Potassium Channel Opener, via Modulation of Mesolimbic Dopaminergic Neurotransmission

Florence Sotty, Trine Damgaard, Liliana P. Montezinho, Arne Mørk, Christina K. Olsen, Christoffer Bundgaard, and Henriette Husum

JPET 328:951-962, 2009

 

3! - Risperidone Long-Acting Injection: A Prospective 3-Year Analysis of Its Use in Clinical Practice

David M. Taylor, Catrin Fischetti, Anna Sparshatt, Arwel Thomas, Delia Bishara, and Victoria Cornelius

J Clin Psychiatry 2009;70(2):196-200

 

3 - Effects of antipsychotic drugs on MK-801-induced attentional and motivational deficits in rats

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Tracie A. Paine and William A. Carlezon Jr.

Neuropharmacology. Volume 56, Issue 4, March 2009, Pages 788-797

 

3 - Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Carlos Figueroa, Martin Brecher, Jennifer E. Hamer-Maansson and Helen Winter

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 2, 17 March 2009, Pages 199-204

 

3 - Effects of acute and chronic administration of MK-801 on c-Fos protein expression in mice brain regions implicated in schizophrenia with or without clozapine

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Dai-Ying Zuo, Yue Cao, Lan Zhang, Hai-Feng Wang and Ying-Liang Wu

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 2, 17 March 2009, Pages 290-295

 

3! - Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Haruhiko Sugino, Takashi Futamura, Yasuhide Mitsumoto, Kenji Maeda and Yoshinori Marunaka

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 2, 17 March 2009, Pages 303-307

 

3! - Relative contribution of antipsychotics, negative symptoms and executive functions to social functioning in stable schizophrenia

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Paola Rocca, Cristiana Montemagni, Filomena Castagna, Michela Giugiario, Mara Scalese and Filippo Bogetto

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 2, 17 March 2009, Pages 373-379

 

3 - Yi-Gan San as Adjunctive Therapy for Treatment-Resistant Schizophrenia: An Open-Label Study

Miyaoka, Tsuyoshi; Furuya, Motohide; Yasuda, Hideaki; Hayashida, Maiko; Nishida, Akira; Inagaki, Takuji; Horiguchi, Jun

Clinical Neuropharmacology:Volume 32(1)January/February 2009pp 6-9

 

3 - The QTc interval and its dispersion in patients receiving two atypical antipsychotics

ORIGINAL PAPER

The QTc interval and its dispersion in patients receiving two atypical antipsychotics

Christoph U. Correll, Anne M. Frederickson, Vicki Figen, Elizabeth J. Ginn-Scott, Rudy A. Pantaleon Moya, John M. Kane and Peter Manu

European Archives of Psychiatry and Clinical Neuroscience. Volume 259, Number 1 / February, 2009: 23-27

 

3! - Comorbid substance abuse and brain morphology in recent-onset psychosis

ORIGINAL PAPER

Comorbid substance abuse and brain morphology in recent-onset psychosis

Thomas Wobrock, Helmut Sittinger, Bernd Behrendt, Roberto D’Amelio and Peter Falkai

European Archives of Psychiatry and Clinical Neuroscience. Volume 259, Number 1 / February, 2009: 28-36

 

5< - Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Catarina Freitas, Felipe Fregni and Alvaro Pascual-Leone

Schizophrenia Research. Volume 108, Issues 1-3, March 2009, Pages 11-24

 

3! - Weight gain with clozapine: 8-year cohort naturalistic study among hospitalized Chinese schizophrenia patients

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Ya-Mei Bai, Jen-Yeu Chen, Tzu-Ting Chen, Chih-Yuan Lin, Pesus Chou, Tung-Ping Su and Chao-Cheng Lin

Schizophrenia Research. Volume 108, Issues 1-3, March 2009, Pages 122-126

 

3 - Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal model

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Araba F. Chintoh, Steve W. Mann, Loretta Lam, Adria Giacca, Paul Fletcher, Jose Nobrega and Gary Remington

Schizophrenia Research. Volume 108, Issues 1-3, March 2009, Pages 127-133

 

3 - Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Xiaohong Hong, Raymond C.K. Chan, Xihang Zhuang, Tingyun Jiang, Xiaona Wan, Junqing Wang, Bo Xiao, Hanhui Zhou, Liyun Jiang and Bilan Weng

Schizophrenia Research. Volume 108, Issues 1-3, March 2009, Pages 151-157

 

3! - Neurological abnormalities among offspring of persons with schizophrenia: Relation to premorbid psychopathology

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Konasale M. Prasad, Richard Sanders, John Sweeney, Debra Montrose, Vaibhav Diwadkar, Diana Dworakowski, Jean Miewald and Matcheri Keshavan

Schizophrenia Research. Volume 108, Issues 1-3, March 2009, Pages 163-169

 

3 - Prevalence and risk of atopic disorders among schizophrenia patients: A nationwide population based study

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Yi-Hua Chen, Hsin-Chien Lee and Herng-Ching Lin

Schizophrenia Research. Volume 108, Issues 1-3, March 2009, Pages 191-196

 

3 - Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Judy L. Thompson, Meredith Kelly, David Kimhy, Jill M. Harkavy-Friedman, Shamir Khan, Julie W. Messinger, Scott Schobel, Ray Goetz, Dolores Malaspina and Cheryl Corcoran

Schizophrenia Research. Volume 108, Issues 1-3, March 2009, Pages 176-181

 

3! - Remission in schizophrenia: Results from a 1-year follow-up observational study

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Antonio Ciudad, Enric Álvarez, Julio Bobes, Luis San, Pepa Polavieja and Inmaculada Gilaberte

Schizophrenia Research. Volume 108, Issues 1-3, March 2009, Pages 214-222

 

3! - Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Diego Novick, Josep Maria Haro, David Suarez, Eduard Vieta and Dieter Nabe

Schizophrenia Research. Volume 108, Issues 1-3, March 2009, Pages 223-230

 

3! - Risk factors for suicide in schizophrenia: Findings from a Swedish population-based case-control study

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Johan Reutfors, Lena Brandt, Erik G. Jönsson, Anders Ekbom, Pär Sparén and Urban Ösby

Schizophrenia Research. Volume 108, Issues 1-3, March 2009, Pages 231-237

 

3 - Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Leslie Citrome, Christopher Reist, Liisa Palmer, Leslie Montejano, Greg Lenhart, Brian Cuffel, James Harnett and Kafi N. Sanders

Schizophrenia Research. Volume 108, Issues 1-3, March 2009, Pages 238-244

 

5 - Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: A double-blind, randomized, placebo-controlled trial

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Grigori Joffe, Viatcheslav Terevnikov, Marina Joffe, Jan-Henry Stenberg, Mark Burkin and Jari Tiihonen

Schizophrenia Research. Volume 108, Issues 1-3, March 2009, Pages 245-251

 

3! - Familial risks of psychotic disorders and schizophrenia among siblings based on hospitalizations in Sweden

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Xinjun Li, Jan Sundquist, Kari Hemminki and Kristina Sundquist

Psychiatry Research. Volume 166, Issue 1, 31 March 2009, Pages 1-6

 

GRATIS 3! - Psychotic Illness in First-Time Mothers with No Previous Psychiatric Hospitalizations: A Population-Based Study

Valdimarsdóttir U, Hultman CM, Harlow B, Cnattingius S, Sparén P

PLoS Med 2009; 6(2): e1000013

 

3! - The Relationship Between Cortical Inhibition, Antipsychotic Treatment, and the Symptoms of Schizophrenia

References and further reading may be available for this article. To view references and further reading you must purchase this article.

Shi-Kai Liu, Paul B. Fitzgerald, Melissa Daigle, Robert Chen and Zafiris J. Daskalakis

Biological Psychiatry. Volume 65, Issue 6, 15 March 2009, Pages 503-509

5 - A Double-Blind, Randomized Comparative Study of Aripiprazole and Olanzapine in Patients with Schizophrenia

References and further reading may be available for this article. To view references and further reading you must purchase this article.

W. Wolfgang Fleischhacker, Robert D. McQuade, Ronald N. Marcus, Donald Archibald, René Swanink and William H. Carson

Biological Psychiatry. Volume 65, Issue 6, 15 March 2009, Pages 510-517

3 - The 'atypicality' of antipsychotics: a concept re-examined and re-defined

Gerhard Gründer, Hanns Hippius & Arvid Carlsson

Nature Reviews Drug Discovery 8, 197-202 (March 2009)

 

4 - Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia

C Bushe, J Sniadecki, AJ Bradley, and V Poole Hoffmann

Journal of Psychopharmacology. First published on February 24, 2009

 

GRATIS 3 - A mGlu2/3 receptor agonist for schizophrenia 
G. J. Marek

Actas Esp Psiquiatr 2008;36(Suppl. 1):37-39

 

3 - Atypical Antipsychotic Drugs and Diabetes Mellitus in the US Food and Drug Administration Database: A Systematic Bayesian Signal Detection Analysis.

Baker AR et al.

Psychopharmacol Bull 2009; 42:11-31

 

GRATIS 3! - Medical Aspects of Catatonia

James L. Levenson

Primary Psychiatry. 2009;16(3):23-26

.

Regresar a RESÚMENES FEBRERO 2009